Principal: DMC Biotechnologies
Sustainable Fermentation for High-Purity Inositols
DMC Biotechnologies is a U.S.-based leader in precision fermentation, producing high-purity myo-inositol and D-chiro-inositol through a cleaner, more efficient, and more sustainable process. DMC’s Dynamic Metabolic Control™ technology enables predictable, scalable fermentation that is transforming the future of sustainable chemical manufacturing.
As DMC’s distribution partner, LBB Specialties is proud to introduce these next-generation ingredients to formulators seeking consistency, transparency, and strong clean-label positioning.
Why Fermented Inositols?
DMC’s fermentation-based approach delivers several key advantages:
- Consistent, high-purity material produced under controlled fermentation
- Cleaner and more sustainable than traditional chemical synthesis
- Multiple clean label opportunities like non-GMO, vegan, 100% bio-based and more
- Manufacturing aimed to decarbonize chemicals, deliver eco-friendly products and a more secure global supply chain
Ingredient Portfolio
DMC specializes in fermented myo-inositol and fermented D-chiro-inositol, each purified without solvents or chemical reagents and produced at pharmaceutical-grade standards. Both play essential roles in metabolic health, hormonal balance, and whole-body wellness.
Myo-Inositol
Plays a central role in cellular signaling, particularly in insulin sensitivity, glucose metabolism, and neurotransmitter function.
D-Chiro-Inositol (DCI)
Is involved in insulin signaling and glucose metabolism, playing a key role in carbohydrate metabolism and ovarian function.
Click here for the KeyPura™ Fermented Inositols Product Brief